Jennifer Blainey


Jennifer has worked in healthcare policy for thirteen years covering oncology, haematology, long term conditions and rare diseases. Prior to joining Hanover, Jennifer worked for the biopharmaceutical company Celgene, spearheading their UK Government Affairs programme. She was responsible for positioning the company as a strategic partner to Government on R&D and its inclusion in the Life Sciences Sector Deal.

Jennifer started her career working in a range of public affairs agencies with clients including Lilly, MSD, Sanofi, Roche, AbbVie, the Eve Appeal, the Stroke Association and National Rheumatoid Arthritis Society. She was a member of the centre-right Bow Group Health Committee and worked as press officer. Jennifer is currently a Senior Associate of the Royal Society of Medicine.